Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor
Authors
Keywords
-
Journal
BIODRUGS
Volume 29, Issue 3, Pages 185-198
Publisher
Springer Nature
Online
2015-05-21
DOI
10.1007/s40259-015-0127-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy
- (2015) Noa Avisar et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Comparison of pharmacokinetics and safety of pegfilgrastim administered by two delivery methods: on-body injector and manual injection with a prefilled syringe
- (2015) Bing-Bing Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hematopoietic Properties of Granulocyte Colony-Stimulating Factor/Immunoglobulin (G-CSF/IgG-Fc) Fusion Proteins in Normal and Neutropenic Rodents
- (2014) George N. Cox et al. PLoS One
- Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy
- (2013) Igor Bondarenko et al. BMC CANCER
- Effectiveness of daily versus non-daily granulocyte colony-stimulating factors in patients with solid tumours undergoing chemotherapy: a multivariate analysis of data from current practice
- (2013) D. Almenar Cubells et al. EUROPEAN JOURNAL OF CANCER CARE
- A Randomized, Non-Inferiority Study Comparing Efficacy and Safety of a Single Dose of Pegfilgrastim versus Daily Filgrastim in Pediatric Patients after Autologous Peripheral Blood Stem Cell Transplant
- (2013) Simone Cesaro et al. PLoS One
- Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
- (2012) Bing-Bing Yang et al. CHEMOTHERAPY
- A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization
- (2012) Silvia Scaramuzza et al. JOURNAL OF CONTROLLED RELEASE
- Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
- (2011) Katy L Cooper et al. BMC CANCER
- Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
- (2011) Bing-Bing Yang et al. CLINICAL PHARMACOKINETICS
- Randomized Phase III Trial of Pegfilgrastim versus Filgrastim after Autologus Peripheral Blood Stem Cell Transplantation
- (2010) Aaron Gerds et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days
- (2010) J. Pillay et al. BLOOD
- A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy
- (2010) J. Randolph Hecht et al. Clinical Colorectal Cancer
- Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies
- (2010) Howard A. Burris et al. Journal of Oncology Practice
- Use of Filgrastim and Pegfilgrastim to Support Delivery of Chemotherapy
- (2009) William Renwick et al. BIODRUGS
- Pegfilgrastim for peripheral CD34+ mobilization in patients with solid tumours
- (2009) F Willis et al. BONE MARROW TRANSPLANTATION
- Pharmacokinetic and pharmacodynamic modelling of the novel human granulocyte colony-stimulating factor derivative Maxy-G34 and pegfilgrastim in rats
- (2009) M. Scholz et al. CELL PROLIFERATION
- Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors
- (2009) Sunday Ocheni et al. LEUKEMIA & LYMPHOMA
- Impact of primary prophylaxis on febrile neutropenia within community practices in the US
- (2009) Dawn Hershman et al. JOURNAL OF MEDICAL ECONOMICS
- Optimal delivery of anthracycline-based chemotherapy in the adjuvant setting improves outcome of breast cancer patients
- (2008) Isabel Chirivella et al. BREAST CANCER RESEARCH AND TREATMENT
- Pegasparaginase: where do we stand?
- (2008) Amer Zeidan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pharmacokinetics and Pharmacodynamics of Pegfilgrastim in Subjects With Various Degrees of Renal Function
- (2008) Bing-Bing Yang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Pharmacology of PEGylation: Balancing PD with PK to Generate Novel Therapeutics
- (2008) C.Simone Fishburn JOURNAL OF PHARMACEUTICAL SCIENCES
- Formulation of Neulasta® (pegfilgrastim)
- (2007) Deirdre Murphy Piedmonte et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search